Why is the Nanosonics share price rocketing 10% today?

Investors are pleased with a big improvement in this company's performance.

| More on:
Man pointing at a blue rising share price graph.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Nanosonics Ltd (ASX: NAN) share price is having a very strong start to the week.

In morning trade, the infection control specialist's shares were up as much as 10% to $3.47.

Why is the Nanosonics share price surging 10%?

Investors have been fighting to get hold of the company's shares on Monday after it released a trading update.

According to the release, Nanosonics delivered strong growth in both capital and consumables/service revenue in the second half compared to the first.

This was particularly the case in the key North America market, which is getting investors excited today.

Management notes that this was driven by additional customer offerings to bridge budget constraints, a number of organisational changes in particular sales territory realignments, and a growing pipeline, together with improvements in sales conversion timelines.

Show me the money

Nanosonics revealed that it expects to report total revenue of approximately $170 million in FY 2024, which is an increase of 2.4% year on year.

This comprises first half revenue of $79.6 million and second half revenue of approximately $90.4 million. The latter represents a half on half increase of 14%.

Nanosonics' second half revenue growth was driven by a 20% half on half increase in capital revenue to $26.4 million and an 11% increase in consumables/service revenue to approximately $64 million.

The company also provided an update on its trophon footprint. It advised that a total of 3,850 trophon units were placed during the year, comprising 2,340 new installed base and 1,510 upgrade units.

For the second half, total units placed were 2,130, up 24% when compared with first half. Whereas new installed base units in the second half were 1,240, which is up 13% half on half. Upgrade unit sales were of 890 for the second half, up 44% on the first half.

The majority of this growth came from North America during the half, with total units placed up 28% to 1,850 and new installed base units up 6% to 1,030.

Nanosonics' CEO and President, Michael Kavanagh, was pleased with the performance. Especially given the challenging trading conditions. He said:

Despite a challenging market environment, the growth opportunity for trophon remains significant. With a growing pipeline for both new installed base and upgrades, it was pleasing to see the sales conversion timelines improve in the second half, which resulted in significant growth in H2 over H1 for capital unit sales.

The Nanosonics share price remains down by almost 30% since this time last year.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Nanosonics. The Motley Fool Australia has positions in and has recommended Nanosonics. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

woman testing substance in laboratory dish, csl share price
Share Market News

After a 73% surge this ASX healthcare share looks far from done

Brokers are upbeat, and some see possible gains of 90% in 2026.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Which biotech's shares are surging higher on US patent news?

Investors like what they see from this drug company.

Read more »

Medical workers examine an xray or scan in a hospital laboratory.
Healthcare Shares

This biotech company's shares are on a tear – again – after another contract win

A new contract with a prestigious US institution spells good news for shareholders.

Read more »

Child with superhero mask and cape flies after jumping on sofa
AI Stocks

3 of the fastest-growing stocks on the planet in 2025

These stocks soared in 2025.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Could CSL shares outperform the ASX 200 in 2026?

After shocking investors in 2025, CSL shares may be setting up for a comeback. Here’s why 2026 could look better.

Read more »

A man holds his head in his hands after seeing bad news on his laptop screen.
Healthcare Shares

Why did CSL shares crash 39% in 2025?

Should you be buying the dip? Let's find out.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Why 4DMedical shares are jumping 14% today

4DMedical shares climb on a new CFO appointment as investors focus on US expansion and rising use of its lung…

Read more »

A business woman flexes her muscles overlooking a city scape below.
Healthcare Shares

Why I plan to buy this incredible ASX 200 stock in 2026

A 33% pullback has put Pro Medicus back in focus. Here’s why I’m preparing to buy its shares in 2026.

Read more »